Cardiac anomalies in chronic renal failure;Anomalies cardiaques chez l'insuffisant renal chronique

Presse Medicale

Volumn 29, Issue 5, 2000, Pages 274-280

  Guerin A ^a,b   Marchais, S ^a   Pannier, B ^a   London, G ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b Centre Hospitalier FH Manhes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CORONARY ARTERY DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HEMODYNAMICS; HUMAN; MORBIDITY; MORTALITY; PERICARDITIS; REVIEW; RISK FACTOR; UREMIA; VALVULAR HEART DISEASE; WEIGHT GAIN;

ANEMIA; ARTERIOSCLEROSIS; CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DIASTOLE; ECHOCARDIOGRAPHY; HEART VALVE DISEASES; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; PERICARDITIS; RENAL DIALYSIS; RISK FACTORS; SYSTOLE; UREMIA;

EID: 0342470438     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Rostand SG, Rutsky EA: Ischemic heart disease in chronic renal failure: management considerations. Semin Dial 1989 ; 2:98-101.
2. Foley RN, Parfrey PS, Harnett JD et al. Clinical and echo-cardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995 ; 47:186-92.
3. London GM, Marchais SJ, Guérin AP, Fabiani F, Métivier F: Cardiovascular function in hemodialysis patients. In Advances in nephrology (vol.20), edited by Grünfeld JP, Bach JF, Funck-Brentano JL, Maxwell MH: St Louis, Mosby Year Book, 1991, pp. 249-73.
4. Hütting J, Kramer W, Schutterle G, Wizemann V. Analysis of left ventricular changes associated with chronic hemodialysis. A noninvasive follow-up study. Nephron 1988 ; 49:284-90.
5. Raine AEG, Margreiter R, Brunner FP et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 1992 ; 7(Suppl. 2):7-35.
6. Grossman W. Cardiac hypertrophy: Useful adaptation or pathological process ? Am J Med 1980 ; 69:576-84.
7. Dzau VJ. The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes. Current Opinion in Nephrology and Hypertension 1993 ; 2:27-32.
8. Calderone A, Takahashi N, Izzo NJ et al. Pressure-and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factors mRNAs. Circulation 1995 ; 92:2385-90.
9. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension. Circ Res 1991 ; 69:107-15.
10. Katz AM. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med 1990 ; 322:100-10.
11. TenEick RE, Houser SR, Bassett AL. Cardiac hypertrophy and altered cellular electrical activity of the myocardium: possible electrophysiological basis for myocardial contractility changes. In Sperelakis N (ed), Physiology and pathophysiology of the heart. 2nd ed., Boston, Kluwer Academic, 1989.
12. Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989 ; 32:286-190.
13. London GM, Fabiani F, Marchais SJ et al. Uremic cardiomyopathy: An inadequate left ventricular hypertrophy. Kidney Int 1987 ; 31:973-80.
14. Aheam DJ, Maher JF. Heart failure as a complication of hemodialysis fistula. Ann Int Med 1972 ; 70:2014.
15. Chaignon M, Chen WT, Tarazi RC, Bravo EL, Nakamoto S. Effect of hemodialysis on blood volume distribution and cardiac output. Hypertension 1981 ; 3:327-32.
16. Foley RN, Parfrey PS, Harnett JD, Kent GR, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 1996 ; 28:53-61.
17. Fellner SK, Lang RM, Neumann A. Cardiovascular consequences of correction of the anemia of renal failure with erythropoietin. Kidney Int 1993 ; 44:1309-15.
18. Silberberg JS, Rahal DP, Patton R, Sniderman AD: Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease. Am J Cardiol 1989 ; 64:222-4.
19. Hütting J. Predictive value of mitral and aortic valve stenosis fot survival in end-stage renal disease on continuous ambulatory peritoneal dialysis. Nephron 1993 ; 64:63-8.
20. London GM, Marchais SJ, Guerin AP. Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemodynamic factors. Kidney Int 1993 ; 43(suppl. 41):S42-9.
21. London GM, Marchais SJ, Safar ME et al. Aortic and large artery compliance in end-stage renal failure. Kidney Int 1990 ; 37:137-42.
22. Marchais SJ, Guerin AP, Pannier B, Levy BI, Safar ME, London GM: Wave reflections and cardiac hypertrophy in chronic uremia: influence of body size. Hypertension 1993 ; 22:876-83.
23. London GM, Guerin AP, Pannier B, Marchais SJ, Benetos A, Safar ME. Increased systolic pressure in chronic uremia: Role of Arterial Wave Reflections. Hypertension 1992 ; 20:10-19.
24. London GM, Guerin AP, Marchais SJ et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996 ; 50:600-8.
25. Mall G, Huther W, Schneider J, Lundin P, Ritz E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant 1990 ; 5:39-44.
26. Amann K, Wiest G, Neusü R, Irzyniec T, Ritz E, Mall G. Vascular hypertrophy in uraemia is independent of hypertension. Am J Hypertens 1995 ; 8:409-17.
27. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance and wave reflection in end-stage renal disease: Comparative effects of ACE inhibition and calcium channel blockers. Circulation 1994 ; 90:2786-96.
28. Robert V, Silvestre J-S, Charlemagne D et al. Biological determinants of aldosterone-induced cardiac fibrosis in rats. Hypertension 1995 ; 26:971-8.
29. Converse RL, Jacobsen TN, Toto RD et al. Sympathetic overactivity in patients with renal failure. N Engl J Med 1992 ; 327:1912-15.
30. Macdonald IL, Uldall R, Buda AJ. The effect of hemodialysis on cardiac rhythm and performance. Clin Nephrol 1981 ; 6:321-7.
31. Bullock RE, Amer HA, Simpson I. Cardiac abnormalities and exercise trolerance in patients receiving renal replacement therapy. Br Med J 1984 ; 289:1479-84.
32. Kramer W, Wizemann V, Mammlein G et al. Cardiac dysfunction in patients on maintenance hemodialysis II: Systolic and diastolic properties of the left ventricle assessed by invasive methods, in Heart In End-Stage Renal Failure, Contrib Nephrol 1986 ; 52:97-109.
33. Rozich JD, Smith B, Thomas JD, Zile MR, Kaiser J, Mann DL. Dialysis-induced alterations in left ventricular filling: Mechanisms and dinical significance. Am J Kidney Dis 1991 ; 3:277-85.
34. Messerli FH, Ventura HO, Elizardi DJ, Dunn FG, Frohlich ED. Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 1984 ; 77:18-22.
35. London GM, Marchais SJ, Safar ME, Genest AF, Guérin AP, Métivier F et al. Aortic and large artery compliance in end-stage renal failure. Kidney Int 1990 ; 37:137-42.
36. Jungers P, Nguyen Khoa T, Massy ZA, Man NK. Incidence des accidents cardio-vasculaires d'origine athéromateuse chez l'urémique chronique : études épidémiologiques en Ile-de-France. Néphrologie 1998 ; 19:489-94.
37. Ritz E, Sommer J, Gnasso A, Haberbosch W. Should hyperlipidemia of renal failure be treated? Kidney Int 1995 ; 28(Suppl.17):S84-6.
38. Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974 ; 290:697-701.
39. Parfrey PS, Foley RN, Harnett JD et al. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 1996 ; 49:1428-34.
40. Manske CL, Wang Y, Rector T, Wilson RF, White CW. Coronary revascularization in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992 ; 340:998-1002.
41. CASS principal investigators and their associates: Coronary artery surgery study (CASS): A randomized trial of coronry artery bypass surgery: Survival data. Circulation 1983 ; 68:939-50.
42. Rinehart AL, Herzog CA, Collins AJ, Flack JM, Ma JZ, Opsahl JA. A comparaison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 1995 ; 25:281-90.
43. Rostand RG, Kirk KA, Rutsky EA. Dialysis ischemic heart disease: insights from coronary angiography. Kidney Int 1984 ; 25:653-9.
44. Kahn JK, Rutherford BD, Conahay DR, Johnson WL, Giorgi LV, Hartzler GO. Short and long term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 1990;119:484-489
45. Buckberg GD, Fixler DE, Archie JP, Hoffman JIE. Experimental subendocardial ischemia after cardiopulmonary bypass. Circ Res 1972 ; 30:37-81.
46. e edition, Dordrecht : Kluwer Academic Publishers, 1996:688-725.